PRESSEMITTEILUNGEN

Paris, and Princeton, New Jersey (ots/PRNewswire) – -No added benefit on the composite primary end-point with the higher dose when entire ACS study population considered- -Important new findings with higher loading dose of PLAVIX(R) for heart patients undergoing coronary angioplasty (PCI)- Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical [...]

Continue reading

Acute Coronary Syndrome, Bmy, Bristol Myers, Bristol Myers Squibb, Cardiovascular Death, Clopidogrel, Clopidogrel Bisulfate, Coronary Angioplasty, Coronary Intervention, Dose Regimen, European Society Of Cardiology, Global Study, Heart Patients, Invasive Strategy, Loading Dose, Princeton New Jersey, Relevant Differences, Sanofi Aventis, Study Population, Subgroup Analysis